Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study
American Journal of Nephrology · 2024
DOI: 10.1159/000540268 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Nephrology, 2024. Verfasst von Zi Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China, tonypedia@126.com. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Glomerular Filtration Rate, Kidney Failure, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Introduction
In 2016, the Oxford Classification of IgA nephropathy (IgAN) updated its scoring system for the glomerular crescents. Despite this, the clinical significance of crescentic lesions in the updated Oxford classification is still unexplored through prospective cohort studies.
Methods
134 patients diagnosed with IgAN accompanied with C2 lesions at Peking University First Hospital were consecutively enrolled and prospectively followed up for analysis. Multivariate Cox regression in combination with LASSO regression was used to analyze risk factors associated with end-stage kidney disease (ESKD).
Results
During biopsy, the mean estimated glomerular filtration rate (eGFR) was 39.3 mL/min/1.73 m2, and the mean proteinuria was 4.4 g/day. The proportion of kidney failure at 1 year, 2 years, and 3 years were 24%, 34%, and 47%, respectively. The results of LASSO in combination with Cox regression showed that mean arterial pressure (hazard ratio [HR] = 1.035, 95% confidence interval [95% CI] 1.013–1.056, p = 0.001), eGFR at biopsy (HR = 0.968, 95% CI [0.948–0.990], p < 0.004) and T2 lesions (HR = 2.490, 95% CI [1.179–5.259], p = 0.017) were independent risk factor associated with ESKD in patients with C2 lesions. Furthermore, based on univariate analyses, we found that patients with kidney function declined more than 50% within 3 months prior to biopsy or pathological findings indicated a proportion of crescents exceeding 50% were both associated with a poor kidney prognosis. Lastly, when the proportion of the crescent was less than 50%, patients receiving combined steroid and immunosuppressant treatment did not exhibit a better renal prognosis than those receiving steroid only.
Conclusion
Patients diagnosed with IgAN and concurrent C2 lesions exhibited a poor clinical prognosis, necessitating more effective treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China, tonypedia@126.com.
- Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China, tonypedia@126.com.
- Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China, tonypedia@126.com.
- Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China.
- Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
- Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
Zitieren
APA
Wang, Z., Zhou, X., Shi, S., Liu, L., Lv, J., & Zhang, H. (2024). Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study. American Journal of Nephrology. https://doi.org/10.1159/000540268
Vancouver
Wang Z, Zhou X, Shi S, Liu L, Lv J, Zhang H. Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study. American Journal of Nephrology. 2024. doi:10.1159/000540268
BibTeX
@article{Wang2024,
author = {Wang, Zi and Zhou, Xujie and Shi, Sufang and Liu, Lijun and Lv, Jicheng and Zhang, Hong},
title = {Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study},
journal = {American Journal of Nephrology},
year = {2024},
doi = {10.1159/000540268}
}
EUVIMED